BiographyDr. Glenn earned his medical degree from New York University (NYU) School of Medicine. He completed his internship and residency in physical medicine and rehabilitation (PM&R) and then a fellowship in spinal cord injury medicine at NYU. In 1982 he joined the faculty of the Dept. of PM&R at Tufts University and the staff of its affiliates New England Medical Center Hospitals, New England Sinai Hospital (NESH), and Greenery Rehabilitation Center. He was Director of Rehabilitation Medicine at Greenery's Brain Injury Program, and then Director of the Brain Injury Program at NESH. From 1993 until 1998, he was Professor and Chairman of the Dept. of Rehabilitation Medicine at Boston University School of Medicine and Chief of Rehabilitation Medicine at Boston Medical Center, where he was the Project Director of the New England Regional Spinal Cord Injury Center's Spinal Cord Injury Model Systems grant. In 1998, he joined the staff of Spaulding Rehabilitation Hospital. He is an Associate Professor of PM&R at Harvard Medical School (HMS). Dr. Glenn was Project Director of the Spaulding/Partners TBI Model System at HMS, a research grant funded by the National Institute on Disability and Rehabilitation Research, from 1998 to 2008. He has been Medical Director of Brain Injury Services in MA for Mentor ABI/NeuroRestorative since 1991 and Medical Director of Community Rehab Care since 1996. Dr. Glenn has been the editor of the Update on Pharmacology column of Journal of Head Trauma Rehabilitation since its inception.
1995-97: Project Director, New England Regional Spinal Cord Injury Center (Boston University Medical Center), funded by the National Institute on Disability and Rehabilitation Research.
1998-2008: Project Director, Spaulding/Partners Traumatic Brain Injury Model System at Harvard Medical School, funded by the National Institute on Disability and Rehabilitation Research.
2007-present: Project Director, Traumatic Brain Injury Model System Follow-up Center at Spaulding Rehabilitation Hospital, funded by the National Institute on Disability and Rehabilitation Research.
2010: Investigator, A multi-center, randomized controlled trial of amantadine for the treatment of agitation following traumatic brain injury, funded by the National Institute on Disability and Rehabilitation Research (primary site: Carolinas Institute, NC).
Glenn MB. Post-concussion disorders. In Frontera W, Silver J, editors. Essentials of Rehabilitation Medicine, 2nd Ed. Philadelphia: Hanley & Belfus, 2008, p. 801-806.
Strangman GE, O'Neil-Pirozzi TM, Goldstein R, Kelkar K, Katz DI, Burke D, Rauch SL, Savage CR, Glenn MB. Prediction of memory rehabilitation outcomes in traumatic brain injury using functional magnetic resonance imaging. Arch Phys Med Rehabil 2008;89:974-81.
O'Neil-Pirozzi TM, Strangman GE, Goldstein R, Katz DI, Savage CR, Kelkar K, Supelana C, Burke D, Rauch SL, Glenn MB. A controlled treatment study of internal memory strategies (I-MEMS) following traumatic brain injury. J Head Trauma Rehabil 2010;25(1):43-51.4.
Glenn MB. Update on pharmacology: Sudden cardiac death and stroke with the use of antipsychotic medications: Implications for clinicians treating individuals with traumatic brain injury. J Head Trauma Rehabil 2010;25(1):68-70.
1. Dowds MM, Lee P, Sheer JB, O'Neil-Pirozzi TM, Xenopoulos-Oddsson A, Goldstein R, Zainea KL, Glenn MB. Electronic reminding technology following traumatic brain injury: Effects on timely task completion. J Head Trauma Rehabil 2011;26(2):
Call the Massachusetts General Hospital physician referral service at 800-711-4644.
Mass General accepts most health insurance plans. Find out what you need to know before coming to Mass General.
Driving to Mass General? Get driving directions or locate a parking lot on the hospital's main campus.